Inflammation-specific peptides and the uses thereof
The invention relates to novel peptides and partial peptide sequences for the diagnosis and therapy of inflammations and sepsis, which are formed in the case of inflammations and/or infections of primates and humans, and their use or the use of antibodies formed against these peptides in diagnosis and therapy.
1. A method for diagnosis of sepsis and/or sepsis-like systemic infections in a patient, comprising testing a biological sample from said patient for the presence of a peptide comprising the sequence of SEQ ID NO.: 4 or SEQ ID NO.: 5 or a partial sequence thereof, wherein said partial sequence comprises the amino acid sequence of SEQ ID NO:1 and wherein the presence of said peptide is indicative of the presence of sepsis and/or sepsis-like systemic infection.
2. The method according to claim 1 , wherein the presence of said peptide in said biological sample is detected by binding of an antibody that binds specifically to said peptide.